Seoul-VC-Connect
Your Connection To Global Investors
Organized By
Organized By
Operated By
Seoul VC Connect helps Seoul-based startups and SMEs craft more effective global fundraising strategies.
About the Program
Operated by Seoul Metropolitan Government and G3 Partners, Seoul VC Connect is committed to supporting the international fundraising goals of Seoul-based technology startups and SMEs.
We provide promising bio, medical and health startups with wide-ranging support, helping them perfect global-focused investment decks, craft winning global investment strategies and connecting them with international investors.
Key Benefits
Helps companies connect with international investors
Provides support to develop a global-focused investment deck
Helps companies connect with international investors
Interested?
We’d love to tell you more about the services Seoul-VC-Connect offers.
OUR ALUMNUS
BATCH 1
(May 2020 – December 2020)
In Batch 1, some 15 biotech startups attended Digital BIO, the USA’s premier biotech event, held online in June 2020.
AIDOT
AIDOT has an AI diagnostic solution that makes cervical cancer screening faster, easier and more accurate.
AITRICS
AITRICS developed an AI-powered in-patient sepsis risk and alarm for hospitals.
Brilliant & Co.
Brilliant & Co. created portable air quality sensors with apps that track environmental air quality data.
CurioChips
CurioChips is a next-generation organ-on-a-chip company that develops in-vitro 3D cell culture architectures.
Gene Medicine
Gene Medicine develops oncolytic cancer therapies to overcome the limitations of existing treatments.
Genealogy
Genealogy uses AI to improve the quality of DNA test results without any in-person appointments or invasive tests.
HaimBio
HaimBio has developed a metabolism-based cancer therapy that kills cancer cells by starving them of energy.
KaiPharm
KaiPharm uses AI and Big Data to improve drug discovery processes, improving assessment of drug candidates.
Medipixel
Medipixel has created a number of novel solutions that use Artificial Intelligence to assist intervention surgeons.
MX Bio
MX Bio developed a suite of three complementary solutions that can help prevent and cure periodontal disease.
Nu Eyne
Nu Eyne has developed a product that treats dry eye syndrome with electroceutical technology.
Plcoskin
Plcoskin has developed a scaffold that makes breast reconstruction surgery procedures safer and cheaper.
StemLab
StemLab transforms soma cells into stem cells to regenerate central nervous system tissues.
ViroCure
ViroCure develops more effective cancer therapeutics and vaccine development with oncolytic virotherapy.
YBSOFT
YBSOFT has developed a solution that stops wheelchairs from rolling away when sitting down or standing up.
BATCH 2
(July 2020 – December 2020)
In Batch 2, 10 IT companies are taking part in Techcrunch Disrupt 2020 and GSMA Thrive.
DOT
DOT makes Braille watches and Kindle-like smart devices for the visually impaired smaller, lighter, and cheaper.
NOTA
NOTA provides edge-device AI solutions, removing the need for server or cloud computing with low-priced compression, no network connectivity or privacy concerns.
HEXLANT
Hexlant developed a one-stop blockchain-based development platform that enables creating blockchain use cases easily, focusing on usability, security, and uniformity through APIs.
DAMOGO
DamoGo is a mobile app solving the food waste problem for stores and farms by selling food at around half price to consumers.
PERSEUS
Perseus’ hypervisor simplifies in-car infrastructure for security and performance.
WIZSCHOOL
WizSchool is an edtech company, providing engaging environments where kids can learn how to code and to realize their imagination in fun and creative ways.
ONESOFTDIGM
Fitrus, a pocket-sized IoT solution, allows users to monitor seven biometric data types on their mobile app, to save money and pursue a healthy lifestyle.
MONITOR CORP
LuCAS is a Medical Image Diagnostic Assistant Software that helps radiologists to more efficiently read chest CT images.
Follow Our Updates & Annnouncements
Don’t miss the latest news and developments at Seoul-VC-Connect.
PRESS ABOUT US
Follow
CONTACT
hello@seoulvcconnect.com
+82 (0)70-8867-1511
HAVE A QUESTION TO US?